Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial

Publication | Closed Access

DOI

Citations

References

2020

Year

Kazuyuki Shimada, Motoko Yamaguchi, Yoshiko Atsuta, Kosei Matsue, Keijiro Sato, Shigeru Kusumoto, Hirokazu Nagai, Jun Takizawa, Noriko Fukuhara, Koji Nagafuji,

The Lancet Oncology

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematologyPathologyHigh-dose MethotrexatePharmacotherapyIntrathecal ChemotherapyImmunotherapyOncologyRadiation OncologyHealth Sciences